Mental Health
According to SAMHSA’s 2023 National Survey on Drug Use and Health, among adults aged 18 or older in 2023, 22.8% (or 58.7 million people) had any mental illness (AMI) in the past year, 23.0% of adults aged 18 or older (or 59.2 million people) received mental health treatment in the past year, an increase of 3.4 million from 2022.
According to the National Council, patients often overstate their medication adherence and clinicians generally overestimate their own ability to identify and quantify medication non-adherence among their patients. To help prevent adherence misjudgment, the National Council recommends that medication adherence be periodically monitored by laboratory testing.
Mental health medication testing provides enhanced visibility into non-adherence and potential risk factors. Navis Clinical Laboratories® offers an extensive toxicology drug testing menu with over 180 metabolites and parent drugs, including more than 60 mental health testing options.
What are you missing?
An analysis of drug test results from mental health patients where medications were reported as prescribed revealed surprising insights:
65%
Demonstrated
inconsistent results
38%
Tested negative for prescribed medications
19%
Tested positive for
illicit drugs
32%
Tested positive for non-prescribed medications
Analysis of 17,720 samples from mental health patients where a medication was reported as prescribed with the test order; Jan 2018–Sept 2019
Mental Health Medication Adherence Testing
Extensive Mental Health Test Menu
Navis Clinical Laboratories offers an extensive drug testing menu with over 180 metabolites and parent drugs, including more than 60 mental health testing options, in urine and oral fluid.
INTEGRATED RESULTS MANAGEMENT REPORTS
Laboratory results management reports allow you to easily monitor your testing protocols, testing frequency and positivity trends to help you offer better care for your patients.